Search

everythinglearnresearchcommunity

for

Search:↓

Amalaki improves cholesterol, blood sugar, inflammation, and liver function without serious side effects.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

A medicinal cosmetic product for treating Androgenetic Alopecia was developed using plant-based substances, Saw palmetto and Japanese Sophora, with pumpkin seed oil and stabilizers like Carbopol, sodium alginate, xanthan gum, Tween-20 and cetyl alcohol.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Ascorbic acid derivatives improve drug delivery systems.

Adult spiny mice recover better from heart attacks than common lab mice.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Avicennia marina leaf extract can fight Vancomycin-resistant bacteria.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Androgens can help prevent memory problems caused by apoE4.

Aftimoon has potential health benefits for various diseases and could be integrated into modern healthcare.

Amla is a fruit with many health benefits, including improving heart, brain, and hair health, but caution is needed for some medical conditions.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Emulgels are effective for delivering skin medications and cosmetics due to their easy application and controlled release.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Baricitinib was effective in treating both early and late onset alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.